MA23892A1 - Forme cristalline nouvelle du sel d'acide methanesulfonique d'acide 7-(1x,5x, 6x)-6-amino-3 - azabicyclo(3.1.0) hex -3-yl) -6- fluoro -1- (2,4 - difluorophenyl) -1, 4- dihydro -4-oxo - 1, 8 - naphtyridine -3- carboxylique anhydre, procede pour sa preparation et composition la contenant - Google Patents

Forme cristalline nouvelle du sel d'acide methanesulfonique d'acide 7-(1x,5x, 6x)-6-amino-3 - azabicyclo(3.1.0) hex -3-yl) -6- fluoro -1- (2,4 - difluorophenyl) -1, 4- dihydro -4-oxo - 1, 8 - naphtyridine -3- carboxylique anhydre, procede pour sa preparation et composition la contenant

Info

Publication number: MA23892A1
Authority: MA; Morocco
Prior art keywords: naphtyridine; azabicyclo; difluorophenyl; hex; dihydro
Prior art date: 1995-06-06

Application number

MA24262A

Other languages

English (en)

Inventor

Arthur Morris Thomas Jr

A Handanyan Lynne

L Hendrickson Robert

J Johnson Philip

Norris Timothy

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-06

Filing date

1996-06-05

Publication date

1996-12-31

1996-06-05 Application filed by Pfizer filed Critical Pfizer

1996-12-31 Publication of MA23892A1 publication Critical patent/MA23892A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

MA24262A 1995-06-06 1996-06-05 Forme cristalline nouvelle du sel d'acide methanesulfonique d'acide 7-(1x,5x, 6x)-6-amino-3 - azabicyclo(3.1.0) hex -3-yl) -6- fluoro -1- (2,4 - difluorophenyl) -1, 4- dihydro -4-oxo - 1, 8 - naphtyridine -3- carboxylique anhydre, procede pour sa preparation et composition la contenant MA23892A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1995/007211 WO1996039406A1 (fr)	1995-06-06	1995-06-06	NOUVELLE FORME DE CRISTAL DE SEL ANHYDRE D'ACIDE METHANE-SULFONIQUE ET D'ACIDE 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTYRIDINE-3 CARBOXYLIQUE

Publications (1)

Publication Number	Publication Date
MA23892A1 true MA23892A1 (fr)	1996-12-31

Family

ID=39431076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24262A MA23892A1 (fr)	1995-06-06	1996-06-05	Forme cristalline nouvelle du sel d'acide methanesulfonique d'acide 7-(1x,5x, 6x)-6-amino-3 - azabicyclo(3.1.0) hex -3-yl) -6- fluoro -1- (2,4 - difluorophenyl) -1, 4- dihydro -4-oxo - 1, 8 - naphtyridine -3- carboxylique anhydre, procede pour sa preparation et composition la contenant

Country Status (38)

Country	Link
US (1)	US5763454A (fr)
EP (1)	EP0789697B1 (fr)
JP (1)	JP3145715B2 (fr)
KR (1)	KR100191989B1 (fr)
CN (1)	CN1055474C (fr)
AR (1)	AR002753A1 (fr)
AU (1)	AU703634B2 (fr)
BG (1)	BG62443B1 (fr)
BR (1)	BR9602630A (fr)
CA (1)	CA2223404C (fr)
CZ (1)	CZ285878B6 (fr)
DE (1)	DE69503066T2 (fr)
DK (1)	DK0789697T3 (fr)
DZ (1)	DZ2046A1 (fr)
ES (1)	ES2117426T3 (fr)
FI (1)	FI974441A7 (fr)
HR (1)	HRP960267B1 (fr)
HU (1)	HUP9601540A3 (fr)
IL (1)	IL118488A (fr)
IS (1)	IS4351A (fr)
LV (1)	LV11619B (fr)
MA (1)	MA23892A1 (fr)
NO (1)	NO305599B1 (fr)
NZ (1)	NZ286735A (fr)
OA (1)	OA10293A (fr)
PE (1)	PE38097A1 (fr)
PL (1)	PL314604A1 (fr)
RU (1)	RU2125571C1 (fr)
SG (1)	SG54339A1 (fr)
SI (1)	SI9600185A (fr)
SK (1)	SK280535B6 (fr)
TN (1)	TNSN96084A1 (fr)
TW (2)	TW580389B (fr)
UA (1)	UA44718C2 (fr)
UY (1)	UY25459A1 (fr)
WO (1)	WO1996039406A1 (fr)
YU (1)	YU34596A (fr)
ZA (1)	ZA964647B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020032216A1 (en)	1997-03-21	2002-03-14	Lg Chemical Ltd.	Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr)	1997-03-21	1998-10-01	Lg Life Sciences Ltd	Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es)	1997-08-01	1999-01-08	Pfizer Prod Inc	Composiciones parenterales de alatroflaxacino
DE19800214A1 (de)	1998-01-06	1999-07-15	Knoll Ag	Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) *	1998-01-16	2006-03-28	Pfizer Inc.	Process for preparing naphthyridones and intermediates
GB9818258D0 (en) *	1998-08-21	1998-10-14	Pfizer Ltd	Antifungal compositions
HN1999000141A (es) *	1998-09-03	2000-06-19	Pfizer Prod Inc	Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) *	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
ES2164520B1 (es) *	1999-03-16	2003-04-01	Medichem Sa	"procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en)	1999-06-04	2001-05-29	Pfizer Inc.	Trovafloxacin oral suspensions
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
GB9920917D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
US6660864B2 (en)	2001-06-29	2003-12-09	Grayson Walker Stowell	Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en)	2001-06-29	2003-06-03	Grayson Walker Stowell	Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en)	2001-06-29	2002-05-14	Grayson Walker Stowell	Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en)	2001-06-29	2003-03-11	Grayson Walker Stowell	Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en)	2001-06-29	2003-12-02	Grayson Walker Stowell	Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en)	2001-06-29	2003-07-22	Grayson Walker Stowell	Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko)	2002-04-08	2005-09-28	주식회사 엘지생명과학	게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) *	2011-12-30	2012-06-27	天津市嵩锐医药科技有限公司	一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) *	2013-01-11	2017-12-21	參天製藥股份有限公司	內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5164402A (en) *	1989-08-16	1992-11-17	Pfizer Inc	Azabicyclo quinolone and naphthyridinone carboxylic acids
PL166381B1 (pl) *	1989-08-16	1995-05-31	Pfizer	Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
CZ286896B6 (en) *	1994-01-18	2000-07-12	Pfizer	Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
GB2289674A (en) *	1994-05-23	1995-11-29	Pfizer	Antibacterial naphthyridine

1995
- 1995-06-06 DE DE69503066T patent/DE69503066T2/de not_active Expired - Fee Related
- 1995-06-06 US US08/849,300 patent/US5763454A/en not_active Expired - Fee Related
- 1995-06-06 FI FI974441A patent/FI974441A7/fi unknown
- 1995-06-06 SK SK719-96A patent/SK280535B6/sk unknown
- 1995-06-06 EP EP95922240A patent/EP0789697B1/fr not_active Expired - Lifetime
- 1995-06-06 WO PCT/US1995/007211 patent/WO1996039406A1/fr not_active Ceased
- 1995-06-06 JP JP50037497A patent/JP3145715B2/ja not_active Expired - Fee Related
- 1995-06-06 ES ES95922240T patent/ES2117426T3/es not_active Expired - Lifetime
- 1995-06-06 CA CA002223404A patent/CA2223404C/fr not_active Expired - Fee Related
- 1995-06-06 DK DK95922240T patent/DK0789697T3/da active
1996
- 1996-05-13 TW TW089107609A patent/TW580389B/zh not_active IP Right Cessation
- 1996-05-13 TW TW085105632A patent/TW403751B/zh not_active IP Right Cessation
- 1996-05-29 CN CN96110060A patent/CN1055474C/zh not_active Expired - Fee Related
- 1996-05-30 IL IL11848896A patent/IL118488A/en not_active IP Right Cessation
- 1996-05-31 AR ARP960102817A patent/AR002753A1/es unknown
- 1996-06-03 IS IS4351A patent/IS4351A/is unknown
- 1996-06-04 LV LVP-96-172A patent/LV11619B/en unknown
- 1996-06-04 PL PL96314604A patent/PL314604A1/xx unknown
- 1996-06-04 UA UA96062190A patent/UA44718C2/uk unknown
- 1996-06-04 BR BR9602630A patent/BR9602630A/pt not_active Application Discontinuation
- 1996-06-05 NZ NZ286735A patent/NZ286735A/en unknown
- 1996-06-05 ZA ZA9604647A patent/ZA964647B/xx unknown
- 1996-06-05 CZ CZ961625A patent/CZ285878B6/cs not_active IP Right Cessation
- 1996-06-05 HU HU9601540A patent/HUP9601540A3/hu unknown
- 1996-06-05 MA MA24262A patent/MA23892A1/fr unknown
- 1996-06-05 AU AU54749/96A patent/AU703634B2/en not_active Ceased
- 1996-06-05 NO NO962321A patent/NO305599B1/no not_active IP Right Cessation
- 1996-06-05 KR KR1019960020171A patent/KR100191989B1/ko not_active Expired - Fee Related
- 1996-06-05 BG BG100639A patent/BG62443B1/bg unknown
- 1996-06-05 TN TNTNSN96084A patent/TNSN96084A1/fr unknown
- 1996-06-05 DZ DZ960090A patent/DZ2046A1/fr active
- 1996-06-05 RU RU96111026A patent/RU2125571C1/ru not_active IP Right Cessation
- 1996-06-05 SG SG1996009972A patent/SG54339A1/en unknown
- 1996-06-05 YU YU34596A patent/YU34596A/sh unknown
- 1996-06-06 HR HR960267A patent/HRP960267B1/xx not_active IP Right Cessation
- 1996-06-06 SI SI9600185A patent/SI9600185A/sl not_active IP Right Cessation
- 1996-06-06 OA OA60835A patent/OA10293A/fr unknown
- 1996-06-06 PE PE1996000421A patent/PE38097A1/es not_active Application Discontinuation
1999
- 1999-04-06 UY UY25459A patent/UY25459A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP3145715B2 (ja)	2001-03-12
SK71996A3 (en)	1997-03-05
OA10293A (en)	1997-09-19
HRP960267B1 (en)	2000-06-30
HU9601540D0 (en)	1996-07-29
LV11619B (en)	1997-04-20
DE69503066D1 (de)	1998-07-23
TNSN96084A1 (fr)	2005-03-15
KR970001352A (ko)	1997-01-24
HUP9601540A2 (en)	1997-02-28
RU2125571C1 (ru)	1999-01-27
NO962321D0 (no)	1996-06-05
US5763454A (en)	1998-06-09
CA2223404A1 (fr)	1996-12-12
DK0789697T3 (da)	1998-10-19
IS4351A (is)	1996-12-07
NZ286735A (en)	1998-01-26
DE69503066T2 (de)	1998-10-15
AU703634B2 (en)	1999-03-25
NO962321L (no)	1996-12-09
IL118488A0 (en)	1996-09-12
EP0789697B1 (fr)	1998-06-17
KR100191989B1 (ko)	1999-06-15
JPH10506650A (ja)	1998-06-30
SK280535B6 (sk)	2000-03-13
FI974441L (fi)	1997-12-05
BR9602630A (pt)	1998-09-08
UY25459A1 (es)	1999-11-17
PE38097A1 (es)	1997-10-10
TW403751B (en)	2000-09-01
SI9600185A (en)	1997-04-30
AU5474996A (en)	1996-12-19
PL314604A1 (en)	1996-12-09
CN1148596A (zh)	1997-04-30
BG62443B1 (bg)	1999-11-30
HRP960267A2 (en)	1997-08-31
BG100639A (bg)	1997-02-28
HUP9601540A3 (en)	1997-05-28
ES2117426T3 (es)	1998-08-01
ZA964647B (en)	1997-10-22
EP0789697A1 (fr)	1997-08-20
UA44718C2 (uk)	2002-03-15
CZ162596A3 (cs)	1998-09-16
MX9709873A (es)	1998-03-31
CN1055474C (zh)	2000-08-16
IL118488A (en)	1999-01-26
YU34596A (sh)	1999-03-04
WO1996039406A1 (fr)	1996-12-12
SG54339A1 (en)	1998-11-16
CZ285878B6 (cs)	1999-11-17
LV11619A (lv)	1996-12-20
FI974441A0 (fi)	1997-12-05
CA2223404C (fr)	2001-01-16
DZ2046A1 (fr)	2002-10-22
AR002753A1 (es)	1998-04-29
NO305599B1 (no)	1999-06-28
FI974441A7 (fi)	1997-12-05
TW580389B (en)	2004-03-21

Similar Documents

Publication	Publication Date	Title
DZ2046A1 (fr)	2002-10-22	Forme cristalline nouvelle du sel d'acide méthanesulfonique d'acide 7-Ä(1alpha,5alpha,6alphaÜ-6-amino-3-azabicycloÄ3.1.0Ühex-3-yl)-6-fluoro -1-(2,4-difluorophényl)-1,4 dihydro-4-oxo-1,8-naphtyridine-3-carboxylique anhydre, procédé pour sa préparationet composition pharmaceutique la contenant.
KR0183374B1 (ko)	1999-05-01	혈관평활근 이완작용을 가진 화합물과 그의 제조방법
CA1205476A (fr)	1986-06-03	Derives de substitution acyles d'acides actahydro-1h-indole-2-carboxyliques
EP0393926B1 (fr)	1994-09-21	Dérivés de la 1-amino-isoquinoléine
HUT56102A (en)	1991-07-29	Process for producing 1h-imidazo(4,5-b)quinolinyl oxyalkanecarboxylic acid amides having increased water solubility, as well as pharmaceutical compositions comprising same
TNSN97070A1 (fr)	2005-03-15	Derives d'imidazole substitues, procede pour leur preparation, et compositions les contenant
RU2001118035A (ru)	2003-04-20	Этанолят азитромицина, процесс получения и содержащие его фармацевтические составы
TNSN01131A1 (fr)	2005-11-10	Derives de phenoxybenzylamine nouveaux, procede pour leur preparation et compositions les contenant.
JP2001512100A (ja)	2001-08-21	カスパーゼおよびアポトーシス
TNSN91001A1 (en)	1992-10-25	Hemi-hydrate
CA2119755A1 (fr)	1993-04-15	Derives de benzonaphtyridine-1,8 et compositions antimicrobiennes
DZ3074A1 (fr)	2004-07-20	Formes cristallines du (R)-(+)-N-Ä3-Ä1 berizoyl-3-(3,4-dichlorophényl)pipéridin-3YLÜpropyl-1-YLÜ-4-phénylpipéridin-4-YLÜ-N-méthylacetamide(osanétant) et procédé pour leur préparation.
NO994263D0 (no)	1999-09-02	FremgangsmÕte ved krystallisering av laktitol
SI9620018A (en)	1997-12-31	Process for producing n-(d-alpha-methyl-beta-mercaptopropionyl)-l-proline and its intermediate
DZ3051A1 (fr)	2004-03-27	Formes polymorphes du citrate d'azo-bicycloÄ2,2,2Ü-oct-3-ylamine cristallin, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DE69706487D1 (de)	2001-10-11	Benzopyranopyridoncarbonsäuren und Verfahren zu ihrer Herstellung
US5498716A (en)	1996-03-12	2-amino naphthyridine derivative, its preparation and its use
AU658662B2 (en)	1995-04-27	Process for the preparation of a dextrogyral isomer of an isoindolinone derivative
JPH06345763A (ja)	1994-12-20	ロラカルベフ二水和物をロラカルベフ一水和物に変換する方法
MA22597A1 (fr)	1993-04-01	Procede pour la preparation de compositions contenant du sous-salicylate de bismuth .
FR2776675B1 (fr)	2004-09-24	PROCEDE POUR LA CROISSANCE DE CRISTAUX POUR FILMS MINCES D'OXYDE biSrCaCuO
FR2794449B1 (fr)	2001-10-19	Procede d'epuration des liqueurs d'aluminate de sodium contenant de l'oxalate de sodium permettant de valoriser les residus
RU1775362C (ru)	1992-11-15	Способ получени дес тиводного сульфата натри
KR20010041947A (ko)	2001-05-25	결정 형태의 파록세틴
FR2785895B1 (fr)	2001-01-19	Procede d'epuration des liqueurs d'aluminate de sodium contenant de l'oxalate de sodium permettant d'augmenter la quantite d'hydrate d'alumine produit